• Most Popular
  • Most Shared

US FDA says has several issues with Theravance drug

Mon Feb 25, 2008 12:02pm EST

Stocks

   

WASHINGTON, Feb 25 (Reuters) - The U.S. Food and Drug Administration said on Monday it canceled Wednesday's advisory panel review of an experimental Theravance Inc (THRX.O) antibiotic to allow time for the agency to resolve "several outstanding issues."

Stocks  |  Regulatory News

The FDA, in a notice sent to reporters, did not explain the issues with the antibiotic, called telavancin. The agency said it would continue evaluating the drug and would schedule an advisory panel meeting in the future "as needed."

Stocks
Regulatory News


More from Reuters

Photo

Time Warner Cable, Fox at impasse; blackout looms

NEW YORK (Reuters) - About 13 million Time Warner Cable Inc subscribers were to lose most Fox programing at midnight on Thursday unless the cable service provider reached a last-minute deal to pay fees to News Corp to broadcast the shows.

» More Top News
A customer is served at a counter inside a foreign exchange store displaying a poster of various banknotes including the Chinese yuan or renminbi (RMB) in Hong Kong November 20, 2009. REUTERS/Bobby Yip
OUTLOOK 2010:

Be careful what you wish for

Pressure on China to loosen its grip on the yuan will continue but the U.S. should tread carefully. Here are five world market issues to watch.  Full Article 

Global Markets
Clients work out on machines at the Bally Total Fitness facility in Arvada, Colorado June 15, 2009. REUTERS/Rick Wilking

Get real with resolutions

We make them and we break them: The secret to keeping them is to avoid the impossible dream.  Full Article 

Lifestyle